Feedback / Questions
NKTR-0165 - Nektar Therapeutics, Biolojic Design
https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-research-collaboration-with-ucsf-and-dr-stephen-hauser-for-nktr-0165-a-tumor-necrosis-factor-receptor-2-tnfr2-antibody-in-multiple-sclerosis-302689175.html
Feb 17, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next